D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types PR Newswire (Press Release) 04:16
ACROBiosystems Showcases AI-Driven Innovation at AACR 2026, Empowering Next-Generation Biologics Discovery PR Newswire (Press Release) 15:02 Tue, 28 Apr
[AACR 2026] ABL Bio advances bispecific ADCs, eyes dual-payload shift Korea Biomedical Review 07:15 Mon, 27 Apr
A Look At Cogent Biosciences (COGT) Valuation After New KRAS And ErbB2 Data At AACR 2026 Simply Wall St 06:58 Mon, 27 Apr
Lantern Pharma to Debut Public Demonstration of withZeta.ai - A Platform to Conquer Rare Cancers on April 30 Following Aacr 2026 Scientific Debut Business Wire (Press Release) 12:51 Fri, 24 Apr
AACR 2026: Researchers define a mechanism‑driven strategy for targeting p53‑mutant cancers ecancer 11:40 Fri, 24 Apr
[AACR 2026] Samsung Biologics uses organoids to narrow preclinical–clinical gap in oncology Korea Biomedical Review 05:50 Thu, 23 Apr
AACR 2026 | Abbisko Therapeutics Showcases Six Research Advances Highlighting pan-KRAS, 4th Generation EGFR, and Synthetic Lethality Approaches PR Newswire (Press Release) 04:41 Thu, 23 Apr
AACR 2026: Roswell Park Researchers Define a Mechanism Driven Strategy for Targeting p53 Mutant Cancers Newswise (Press Release) 16:04 Wed, 22 Apr
AACR 2026: Novel approach prevents cancer progression, spares surgery for majority of patients with precancerous... ecancer 14:43 Wed, 22 Apr
AACR 2026: Early myocarditis onset after immunotherapy may predict treatment-related fatality ecancer 13:12 Wed, 22 Apr
Vyome Presents Transformational Vt-1953 Phase 2 Clinical Study Data at Prestigious Aacr 2026 Business Wire (Press Release) 13:06 Wed, 22 Apr
RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026 PR Newswire (Press Release) 13:05 Wed, 22 Apr
AACR 2026: Exposure to wildfire smoke may be linked to increased risk of developing several cancers ecancer 13:01 Wed, 22 Apr
AACR 2026: Intralesional nivolumab may be effective against precancerous oral lesions ecancer 12:51 Wed, 22 Apr
[AACR 2026] SK biopharmaceuticals highlights ‘theranostic’ strategy in RPT at AACR 2026 Korea Biomedical Review 08:01 Wed, 22 Apr
[AACR 2026] Curocell tackles CAR-T ‘self-attack,’ advances allogeneic CD5 therapy Korea Biomedical Review 07:07 Wed, 22 Apr
STCube highlights 1st-line potential of nelmastobart in NSCLC at AACR 2026 Korea Biomedical Review 03:05 Wed, 22 Apr
Nuvation Bio Announces IBTROZI® (Taletrectinib) Showed Highly Durable Responses in Longer-Term Follow-up Data from Pivotal Studies Presented at AACR 2026 PR Newswire (Press Release) 23:01 Tue, 21 Apr
Zymeworks (ZYME) Broadens ADC Toolkit at AACR 2026 Is Its Oncology Platform Taking Shape? Simply Wall St 22:57 Tue, 21 Apr
Synthekine Presents Updated Clinical and Translational Data Demonstrating Strong Activity for Stk‑012 in First‑Line Non‑Squamous Nsclc in Oral Presentation at Aacr 2026 Business Wire (Press Release) 22:42 Tue, 21 Apr
AACR 2026: New platform uses machine learning to predict responses in patients with lung cancer ecancer 18:22 Tue, 21 Apr
AACR 2026:BCMA-directed CAR T-cell therapy may be effective against high-risk smouldering multiple myeloma ecancer 18:22 Tue, 21 Apr
AACR 2026: A machine learning model that uses DNA methylation patterns may help identify the origin of cancers of... ecancer 18:22 Tue, 21 Apr
Verismo Therapeutics Presents Preclinical Data at AACR 2026 for SynKIR™-310 KIR-CAR Indicating Superior Preclinical Activity in B Cell Malignancies and Early Clinical Efficacy PR Newswire (Press Release) 17:05 Tue, 21 Apr
AACR 2026: New KIR-CAR T cell therapy shows promise in multiple solid cancers ecancer 16:40 Tue, 21 Apr
AACR 2026: A deep learning pathomics platform may help predict response to immunotherapy in lung cancer patients ecancer 16:40 Tue, 21 Apr
AACR 2026:Sleep deprivation disrupts gut microbiota, worsening colorectal cancer outcomes ecancer 15:39 Tue, 21 Apr
Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at Aacr 2026 Business Wire (Press Release) 11:07 Tue, 21 Apr
[AACR 2026] SynKIR-110 shows early promise in solid tumor CAR-T therapy Korea Biomedical Review 06:05 Tue, 21 Apr
Cadonilimab Combination Demonstrates Promising Survival Benefit in Locally Advanced Pancreatic Cancer: Phase II COMPASSION-26 Data Presented at AACR 2026 PR Newswire (Press Release) 03:56 Tue, 21 Apr
Rznomics Reports Interim Clinical Data for RZ-001 in Hepatocellular Carcinoma at AACR 2026 Demonstrating Encouraging Efficacy and Favorable Safety Profile PR Newswire (Press Release) 03:16 Tue, 21 Apr
Verismo Therapeutics' Initial Clinical Data from STAR-101 Phase 1 Trial of SynKIR™-110 KIR-CAR Presented at AACR 2026 Plenary Session PR Newswire (Press Release) 18:19 Mon, 20 Apr
AACR 2026: Revolution’s next prospect, Merck’s reveal and a lung cancer battle BioPharma Dive 15:56 Mon, 20 Apr
AACR 2026 Oral Presentation: Abogen Presents Preliminary Results of ABO2203 (mRNA-Encoded CD3×CD19 TCE) from First-in-Human Clinical Study in R/R B-NHL PR Newswire (Press Release) 15:02 Mon, 20 Apr
AACR 2026: Real-World Data Show Targeted Therapy Extends Survival in Aggressive Form of Colorectal Cancer Newswise (Press Release) 14:48 Mon, 20 Apr
AACR 2026: Phase 1 study explores toxicity reduction in combination of trastuzumab deruxtecan and olaparib in... ecancer 13:10 Mon, 20 Apr
